No Baggage……. Just Better

If one sees the trends in the CRO universe in last three years, multiple CROs have been red flagged by EMA, USFDA and WHO. Hundreds of BE studies have been required to redone at the tremendous cost to the pharma companies. Your products were mandated to be taken off the retail shelves at a considerable cost to your company’s bottom line. You had to do the BE studies again and resubmit the data to the regulators. Your prescribing doctors could not prescribe your products to their patients though they wanted to. We understand your pain.

At Bion clinicals, you have no fear of our past catching up with your products!

When Bion Clinicals was coming into existence in 2022, we have faced this regulatory environment since our inception. Hence our approach, processes and our orientation are geared towards complete transparency and accountability – to both our clients and to our regulators.

Ten years down the line, even when we have done hundreds of BE studies, we will still be safe for you. Because we are Unburdened. Unmatched. Unstoppable.

We offer you the quality driven work with world class infrastructure. We focus on delivering efficiency, transparency, and reliability without the weight of outdated processes.